berberine has been researched along with Cancer of Prostate in 13 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Berberine has displayed significant anti-prostate cancer activities." | 5.40 | Mitochondrial protein cyclophilin-D-mediated programmed necrosis attributes to berberine-induced cytotoxicity in cultured prostate cancer cells. ( Gao, XH; Guo, F; Wu, YL; Zhang, LY, 2014) |
| "Berberine (Brb) is an active isoquinoline alkaloid occurring in various common plant species, with well-known potential for cancer therapy." | 1.51 | Anionic and Cationic Vitamin E-TPGS Mixed Polymeric Phospholipid Micellar Vehicles. ( Elbayoumi, T; Yao, M, 2019) |
| "Berberine is a well‑known component of the Chinese herbal medicine Huanglian (Coptis chinensis), and is capable of inhibiting the proliferation of multiple cancer cell lines." | 1.42 | Berberine targets epidermal growth factor receptor signaling to suppress prostate cancer proliferation in vitro. ( Huang, ZH; Li, QX; Wang, WL; Wang, Y; Wu, JL; Zheng, HF; Zhong, LF, 2015) |
| "Berberine is a natural alkaloid with significant antitumor activities against many types of cancer cells." | 1.42 | Berberine inhibits the metastatic ability of prostate cancer cells by suppressing epithelial-to-mesenchymal transition (EMT)-associated genes with predictive and prognostic relevance. ( Huang, CC; Lai, IL; Lee, KH; Liu, CH; Sia, P; Tang, WC; Wu, MH; Yang, PM, 2015) |
| "Berberine is a quaternary ammonium salt that is extracted from plants." | 1.42 | Berberine inhibits the proliferation of prostate cancer cells and induces G₀/G₁ or G₂/M phase arrest at different concentrations. ( Du, S; Lu, W; Wang, J, 2015) |
| "Berberine may inhibit the expression of HIF-1α and VEGF and thus confer radiosensitivity on prostatic cancer cells." | 1.40 | Berberine inhibits the expression of hypoxia induction factor-1alpha and increases the radiosensitivity of prostate cancer. ( Cai, J; Dai, S; Huang, G; Kang, Y; Li, D; Ma, J; Ma, Z; Mao, W; Sun, X; Tao, G; Wang, J; Wang, Z; Yang, B; Yang, X; Zhang, C; Zhang, Q, 2014) |
| "Berberine has displayed significant anti-prostate cancer activities." | 1.40 | Mitochondrial protein cyclophilin-D-mediated programmed necrosis attributes to berberine-induced cytotoxicity in cultured prostate cancer cells. ( Gao, XH; Guo, F; Wu, YL; Zhang, LY, 2014) |
| "Berberine has been shown to possess anti-tumor activity against a wide spectrum of cancer cells." | 1.38 | Berberine, a genotoxic alkaloid, induces ATM-Chk1 mediated G2 arrest in prostate cancer cells. ( Gong, Y; Li, B; Liu, Q; Liu, Z; Shao, C; Sun, Z; Wang, Y; Zhang, X; Zhou, H, 2012) |
| "Berberine treatment inhibited cell cancer growth in a concentration (0-50 microM) and time- (0-48 h) dependent manner without any growth inhibition in normal human prostate epithelial PWR-1E cells." | 1.35 | Berberine inhibits p53-dependent cell growth through induction of apoptosis of prostate cancer cells. ( Choi, MS; Han, SB; Hong, JT; Jung, HY; Kim, SM; Lee, YM; Moon, DC; Oh, JH; Yoo, HS, 2009) |
| "The treatment of human prostate cancer cells (PC-3) with berberine induced dose-dependent apoptosis but this effect of berberine was not seen in non-neoplastic human prostate epithelial cells (PWR-1E)." | 1.35 | Berberine-induced apoptosis in human prostate cancer cells is initiated by reactive oxygen species generation. ( Katiyar, S; Katiyar, SK; Meeran, SM, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 8 (61.54) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Berlin, IG | 1 |
| Jennings, CC | 1 |
| Shin, S | 1 |
| Kenealey, J | 1 |
| Yao, M | 1 |
| Elbayoumi, T | 1 |
| Zhang, Q | 1 |
| Zhang, C | 1 |
| Yang, X | 1 |
| Yang, B | 1 |
| Wang, J | 2 |
| Kang, Y | 1 |
| Wang, Z | 1 |
| Li, D | 1 |
| Huang, G | 1 |
| Ma, Z | 1 |
| Sun, X | 1 |
| Cai, J | 1 |
| Tao, G | 1 |
| Dai, S | 1 |
| Mao, W | 1 |
| Ma, J | 1 |
| Zhang, LY | 1 |
| Wu, YL | 1 |
| Gao, XH | 1 |
| Guo, F | 1 |
| Huang, ZH | 1 |
| Zheng, HF | 1 |
| Wang, WL | 1 |
| Wang, Y | 2 |
| Zhong, LF | 1 |
| Wu, JL | 1 |
| Li, QX | 1 |
| Liu, CH | 1 |
| Tang, WC | 1 |
| Sia, P | 1 |
| Huang, CC | 1 |
| Yang, PM | 1 |
| Wu, MH | 1 |
| Lai, IL | 1 |
| Lee, KH | 1 |
| Lu, W | 1 |
| Du, S | 1 |
| Muralimanoharan, SB | 1 |
| Kunnumakkara, AB | 1 |
| Shylesh, B | 1 |
| Kulkarni, KH | 1 |
| Haiyan, X | 1 |
| Ming, H | 1 |
| Aggarwal, BB | 1 |
| Rita, G | 1 |
| Kumar, AP | 1 |
| Choi, MS | 1 |
| Oh, JH | 1 |
| Kim, SM | 1 |
| Jung, HY | 1 |
| Yoo, HS | 1 |
| Lee, YM | 1 |
| Moon, DC | 1 |
| Han, SB | 1 |
| Hong, JT | 1 |
| Li, J | 1 |
| Cao, B | 1 |
| Liu, X | 1 |
| Fu, X | 1 |
| Xiong, Z | 1 |
| Chen, L | 1 |
| Sartor, O | 1 |
| Dong, Y | 1 |
| Zhang, H | 1 |
| Liu, Q | 1 |
| Liu, Z | 1 |
| Li, B | 1 |
| Sun, Z | 1 |
| Zhou, H | 1 |
| Zhang, X | 1 |
| Gong, Y | 1 |
| Shao, C | 1 |
| Mantena, SK | 1 |
| Sharma, SD | 1 |
| Katiyar, SK | 2 |
| Meeran, SM | 1 |
| Katiyar, S | 1 |
13 other studies available for berberine and Cancer of Prostate
| Article | Year |
|---|---|
Utilizing mixture design response surface methodology to determine effective combinations of plant derived compounds as prostate cancer treatments.
Topics: Androgens; Berberine; Cell Line, Tumor; Docetaxel; Emodin; Humans; Male; Phytochemicals; Prostatic N | 2023 |
Anionic and Cationic Vitamin E-TPGS Mixed Polymeric Phospholipid Micellar Vehicles.
Topics: Antineoplastic Agents; Berberine; Cell Line, Tumor; Drug Delivery Systems; Humans; Hydrophobic and H | 2019 |
Berberine inhibits the expression of hypoxia induction factor-1alpha and increases the radiosensitivity of prostate cancer.
Topics: Animals; Apoptosis; Berberine; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Dru | 2014 |
Mitochondrial protein cyclophilin-D-mediated programmed necrosis attributes to berberine-induced cytotoxicity in cultured prostate cancer cells.
Topics: Berberine; Cell Line, Tumor; Cell Survival; Cyclophilins; Humans; Male; Mitochondrial Proteins; Necr | 2014 |
Berberine targets epidermal growth factor receptor signaling to suppress prostate cancer proliferation in vitro.
Topics: Apoptosis; Berberine; Cell Cycle; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell | 2015 |
Berberine inhibits the metastatic ability of prostate cancer cells by suppressing epithelial-to-mesenchymal transition (EMT)-associated genes with predictive and prognostic relevance.
Topics: Antineoplastic Agents, Phytogenic; Berberine; Biomarkers, Tumor; Bone Morphogenetic Protein 7; Cell | 2015 |
Berberine inhibits the proliferation of prostate cancer cells and induces G₀/G₁ or G₂/M phase arrest at different concentrations.
Topics: Animals; Antineoplastic Agents; Apoptosis; Berberine; Cell Cycle Checkpoints; Cell Line, Tumor; Cell | 2015 |
Butanol fraction containing berberine or related compound from nexrutine inhibits NFkappaB signaling and induces apoptosis in prostate cancer cells.
Topics: Adenocarcinoma; Apoptosis; Berberine; Butanols; Cell Line, Tumor; Cell Proliferation; Humans; I-kapp | 2009 |
Berberine inhibits p53-dependent cell growth through induction of apoptosis of prostate cancer cells.
Topics: Animals; Apoptosis; Berberine; Cell Cycle; Cell Proliferation; Cells, Cultured; Down-Regulation; Hum | 2009 |
Berberine suppresses androgen receptor signaling in prostate cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Berberine; Cell Line, Tumor; Cell Nucleus; Cell Prolifera | 2011 |
Berberine, a genotoxic alkaloid, induces ATM-Chk1 mediated G2 arrest in prostate cancer cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Berberine; Cell Cycle Checkpoints; Cell Division; Cell Li | 2012 |
Berberine, a natural product, induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells.
Topics: Androgens; Antineoplastic Agents, Phytogenic; Apoptosis; Berberine; Carcinoma; Caspase 3; Caspase In | 2006 |
Berberine-induced apoptosis in human prostate cancer cells is initiated by reactive oxygen species generation.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Berberine; Caspase 3; C | 2008 |